SQZ vs. SGLY, PSIG, USDP, CISS, MOND, AIRTP, BLDEW, RA, IMPPP, and PXSAW
Should you be buying SQZ Biotechnologies stock or one of its competitors? The main competitors of SQZ Biotechnologies include Singularity Future Technology (SGLY), PSI Group (PSIG), USD Partners (USDP), C3is (CISS), Mondee (MOND), Air T (AIRTP), Blade Air Mobility (BLDEW), Brookfield Real Assets Income Fund (RA), Imperial Petroleum (IMPPP), and Pyxis Tankers (PXSAW). These companies are all part of the "transportation" industry.
SQZ Biotechnologies vs.
SQZ Biotechnologies (NYSE:SQZ) and Singularity Future Technology (NASDAQ:SGLY) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their community ranking, institutional ownership, valuation, earnings, profitability, analyst recommendations, dividends, media sentiment and risk.
Singularity Future Technology has a net margin of -132.89% compared to SQZ Biotechnologies' net margin of -369.96%. Singularity Future Technology's return on equity of -25.97% beat SQZ Biotechnologies' return on equity.
SQZ Biotechnologies received 10 more outperform votes than Singularity Future Technology when rated by MarketBeat users.
38.5% of SQZ Biotechnologies shares are owned by institutional investors. Comparatively, 4.1% of Singularity Future Technology shares are owned by institutional investors. 16.0% of SQZ Biotechnologies shares are owned by insiders. Comparatively, 10.2% of Singularity Future Technology shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
SQZ Biotechnologies has a beta of 2.34, meaning that its share price is 134% more volatile than the S&P 500. Comparatively, Singularity Future Technology has a beta of 0.99, meaning that its share price is 1% less volatile than the S&P 500.
Singularity Future Technology has lower revenue, but higher earnings than SQZ Biotechnologies. Singularity Future Technology is trading at a lower price-to-earnings ratio than SQZ Biotechnologies, indicating that it is currently the more affordable of the two stocks.
In the previous week, Singularity Future Technology had 1 more articles in the media than SQZ Biotechnologies. MarketBeat recorded 1 mentions for Singularity Future Technology and 0 mentions for SQZ Biotechnologies. SQZ Biotechnologies' average media sentiment score of 0.95 beat Singularity Future Technology's score of -0.95 indicating that SQZ Biotechnologies is being referred to more favorably in the media.
Summary
Singularity Future Technology beats SQZ Biotechnologies on 7 of the 13 factors compared between the two stocks.
Get SQZ Biotechnologies News Delivered to You Automatically
Sign up to receive the latest news and ratings for SQZ and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
SQZ Biotechnologies Competitors List
Related Companies and Tools
This page (NYSE:SQZ) was last updated on 2/22/2025 by MarketBeat.com Staff
